Company page
Beam Therapeutics Inc.
Beam Therapeutics Inc. is a public company traded under the ticker BEAM in the American market. The company has a market capitalization of approximately $2.58 billion. Beam Therapeutics focuses on developing precision genetic medicines to treat various diseases.
- Ticker
- BEAM:NASDAQ
- Asset type
- Stock
- Market cap
- $2.63B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD